BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 35121998)

  • 1. The current landscape of immunotherapy for pediatric brain tumors.
    Hwang EI; Sayour EJ; Flores CT; Grant G; Wechsler-Reya R; Hoang-Minh LB; Kieran MW; Salcido J; Prins RM; Figg JW; Platten M; Candelario KM; Hale PG; Blatt JE; Governale LS; Okada H; Mitchell DA; Pollack IF
    Nat Cancer; 2022 Jan; 3(1):11-24. PubMed ID: 35121998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions.
    Estevez-Ordonez D; Gary SE; Atchley TJ; Maleknia PD; George JA; Laskay NMB; Gross EG; Devulapalli RK; Johnston JM
    Pediatr Neurosurg; 2023; 58(5):313-336. PubMed ID: 36549282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward.
    Mishra DK; Popovski D; Morris SM; Bondoc A; Senthil Kumar S; Girard EJ; Rutka J; Fouladi M; Huang A; Olson JM; Drissi R
    Neuro Oncol; 2024 Feb; 26(2):226-235. PubMed ID: 37713135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity.
    Finch EA; Duke E; Hwang EI; Packer RJ
    Pediatr Neurol; 2020 Jun; 107():7-15. PubMed ID: 32113728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-cellular immunotherapies in pediatric central nervous system tumors.
    Rumler S
    Front Immunol; 2023; 14():1242911. PubMed ID: 37885882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy approaches for rare pediatric solid tumors: advances and future directions.
    Fierro Pineda JC; Wedekind MF; Glod JW
    Curr Opin Pediatr; 2023 Feb; 35(1):63-74. PubMed ID: 36420774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology.
    Foster JB; Alonso MM; Sayour E; Davidson TB; Persson ML; Dun MD; Kline C; Mueller S; Vitanza NA; van der Lugt J
    Neoplasia; 2023 Aug; 42():100909. PubMed ID: 37244226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunotherapy for pediatric solid tumors.
    Hegde M; Moll AJ; Byrd TT; Louis CU; Ahmed N
    Cytotherapy; 2015 Jan; 17(1):3-17. PubMed ID: 25082406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Therapy for Central Nervous System Metastasis.
    McAvoy MB; Choi BD; Jones PS
    Neurosurg Clin N Am; 2020 Oct; 31(4):627-639. PubMed ID: 32921357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies.
    Casey DL; Cheung NV
    Cancer Immunol Res; 2020 Feb; 8(2):161-166. PubMed ID: 32015013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on new treatments and developments in childhood brain tumors.
    Partap S; Fisher PG
    Curr Opin Pediatr; 2007 Dec; 19(6):670-4. PubMed ID: 18025934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for pediatric brain tumors: past and present.
    Foster JB; Madsen PJ; Hegde M; Ahmed N; Cole KA; Maris JM; Resnick AC; Storm PB; Waanders AJ
    Neuro Oncol; 2019 Oct; 21(10):1226-1238. PubMed ID: 31504801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in cellular immunotherapy for brain/CNS tumors.
    Badhiwala J; Decker WK; Berens ME; Bhardwaj RD
    Expert Rev Neurother; 2013 Apr; 13(4):405-24. PubMed ID: 23545055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical advances in oncolytic virotherapy for pediatric brain tumors.
    Ghajar-Rahimi G; Kang KD; Totsch SK; Gary S; Rocco A; Blitz S; Kachurak K; Chambers MR; Li R; Beierle EA; Bag A; Johnston JM; Markert JM; Bernstock JD; Friedman GK
    Pharmacol Ther; 2022 Nov; 239():108193. PubMed ID: 35487285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System Malignancies.
    Rozowsky JS; Meesters-Ensing JI; Lammers JAS; Belle ML; Nierkens S; Kranendonk MEG; Kester LA; Calkoen FG; van der Lugt J
    Front Immunol; 2022; 13():864423. PubMed ID: 35464481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for brain tumors: understanding early successes and limitations.
    Lieberman NAP; Vitanza NA; Crane CA
    Expert Rev Neurother; 2018 Mar; 18(3):251-259. PubMed ID: 29322843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of cancer immunotherapy for brain tumors: a collaborative workshop.
    Brown CE; Bucktrout S; Butterfield LH; Futer O; Galanis E; Hormigo A; Lim M; Okada H; Prins R; Marr SS; Tanner K
    J Transl Med; 2022 May; 20(1):236. PubMed ID: 35606815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Pediatric Brain Tumors: the Molecular Era and Neuro-immunologic Beginnings.
    Duke ES; Packer RJ
    Curr Neurol Neurosci Rep; 2020 Jun; 20(8):30. PubMed ID: 32564169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
    Pollack IF; Okada H; Chambers WH
    Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.